Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32K Buy
81
+54
+200% +$963 ﹤0.01% 2616
2026
Q1
$515 Sell
27
-55
-67% -$1.06K ﹤0.01% 2117
2025
Q4
$1.34K Sell
82
-128
-61% -$2.25K ﹤0.01% 2191
2025
Q3
$3.95K Buy
210
+122
+139% +$2.19K ﹤0.01% 2248
2025
Q2
$1.78K Buy
88
+41
+87% +$708 ﹤0.01% 2345
2025
Q1
$647 Buy
+47
New +$647 ﹤0.01% 2038
2024
Q3
Sell
-234
Closed -$4.12K 2123
2024
Q2
$4.12K Hold
234
﹤0.01% 1716
2024
Q1
$5.1K Sell
234
-84
-26% -$2.11K ﹤0.01% 1170
2023
Q4
$8.29K Buy
+318
New +$7.26K ﹤0.01% 1095

Other funds holding XP

Clearstead Advisors's XP Position: Q2 2026 in Review

Clearstead Advisors increased its XP (XP) stake by 200% in Q2 2026, buying an estimated $963 and bringing the position to 81 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #2616.

Clearstead Advisors first reported a position in XP in Q4 2023 and has held it in 9 quarters since. The position peaked at $8.29K in Q4 2023. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Clearstead Advisors held 81 shares of XP worth $1.32K as of Q2 2026.
  • Clearstead Advisors bought 54 XP shares in Q2 2026, an estimated $963.
  • XP made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2616 holding.
  • Clearstead Advisors first reported a position in XP in Q4 2023 and has held it in 9 quarters since.
  • Clearstead Advisors's XP position peaked at $8.29K in Q4 2023.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.